201 results
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
3 Nov 23
Entry into a Material Definitive Agreement
5:31pm
” orders, social distancing measures, or other safety measures, (b) workforce reductions, workplace or worksite shutdowns or slowdowns and (c) other
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
10 Aug 23
Entry into a Material Definitive Agreement
4:14pm
and other obligations of a like nature (including those to secure health, safety and environmental obligations) incurred in the Ordinary Course
8-K
EX-2.1
SRNEQ
Sorrento Therapeutics, Inc.
10 Aug 23
Entry into a Material Definitive Agreement
4:14pm
and conditions of employment, wages, hours of work, worker classification, occupational safety and health, background checks, employee trainings, affirmative
8-K
EX-10.1
k40bf
30 Mar 23
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
9:39pm
8-K
EX-99.1
ybp77dwcm1qdhpud
18 Mar 22
Regulation FD Disclosure
4:35pm
425
EX-99.2
yyaqn31b
18 Mar 22
Business combination disclosure
9:03am
425
EX-2.1
s521ey
18 Mar 22
Business combination disclosure
9:03am
425
EX-99.1
derkly ytob
18 Mar 22
Business combination disclosure
9:03am
8-K
EX-99.2
9q6kdi 1lqzsn4qjesmc
18 Mar 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-2.1
z88ir qc9kxy9
18 Mar 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-99.1
omdhq
18 Mar 22
Entry into a Material Definitive Agreement
9:01am
424B7
9psrw588xh1tuv02vd6r
3 Mar 22
Prospectus with selling stockholder info
5:08pm
8-K
EX-99.1
48y 8gccba5fxonxy
21 Jan 22
Other Events
9:28am
8-K
EX-99.1
emwopd04lpbrtar4p f8
20 Jan 22
Other Events
9:01am